Clinical trials: Fetal Cardiac Disorder

Down Syndrome, Edwards Syndrome

Non-Invasive Screening for Fetal Aneuploidy

• Unknown status
• Age: 18 to 54 years
• Observational study

The purpose of this study is to detect whole chromosome abnormalities in maternal blood.

Trial name

NCT02317965

Testing

Maternal Blood Draw

Where

10 sites in United States

Volunteers

340 people

Sponsor

Progenity, Inc.